XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.770
-0.030 (-1.67%)
Nov 20, 2024, 4:00 PM EST - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $22.46 million as of November 21, 2024. Its market cap has increased by 399.11% in one year.
Market Cap
22.46M
Enterprise Value
20.15M
1-Year Change
399.11%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since November 18, 2008, XTL Biopharmaceuticals's market cap has increased from $800.00K to $22.46M, an increase of 2,707.51%. That is a compound annual growth rate of 23.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 9.60M | 74.55% |
| Dec 29, 2023 | 5.50M | -16.67% |
| Dec 30, 2022 | 6.60M | -53.52% |
| Dec 31, 2021 | 14.20M | -8.97% |
| Dec 31, 2020 | 15.60M | 122.86% |
| Dec 31, 2019 | 7.00M | -21.35% |
| Dec 31, 2018 | 8.90M | 41.27% |
| Dec 29, 2017 | 6.30M | 270.59% |
| Dec 30, 2016 | 1.70M | -56.41% |
| Dec 31, 2015 | 3.90M | -15.22% |
| Dec 31, 2014 | 4.60M | -31.34% |
| Dec 31, 2013 | 6.70M | -55.63% |
| Dec 31, 2012 | 15.10M | 106.85% |
| Dec 30, 2011 | 7.30M | 160.71% |
| Dec 31, 2010 | 2.80M | 366.67% |
| Dec 31, 2009 | 600.00K | 100.00% |
| Dec 31, 2008 | 300.00K | -62.50% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inspira Technologies Oxy B.H.N. | 23.13M |
| Lisata Therapeutics | 22.88M |
| IN8bio | 22.23M |
| Pulmatrix | 21.95M |
| Enlivex Therapeutics | 21.62M |
| iBio, Inc. | 21.41M |
| NeuroSense Therapeutics | 21.32M |
| Bolt Biotherapeutics | 21.31M |